4.5 Article

Monosaccharide Derivatives with Low-Nanomolar Lectin Affinity and High Selectivity Based on Combined Fluorine-Amide, Phenyl-Arginine, Sulfur-pi, and Halogen Bond Interactions

期刊

CHEMMEDCHEM
卷 13, 期 2, 页码 133-137

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/cmdc.201700744

关键词

fluorine multipolar interactions; galectin-3; halogen bonds; inhibitors; lectins; sulfur-pi

资金

  1. Swedish Research Council [621-2012-2978]
  2. Royal Physiographic Society (Lund, Sweden)
  3. Knut and Alice Wallenberg Foundation [KAW 2013.0022]
  4. Galecto Biotech AB, Sweden

向作者/读者索取更多资源

The design of small and high-affinity lectin inhibitors remains a major challenge because the natural ligand binding sites of lectin are often shallow and have polar character. Herein we report that derivatizing galactose with un-natural structural elements that form multiple non-natural lectin-ligand interactions (orthogonal multipolar fluorine-amide, phenyl-arginine, sulfur-pi, and halogen bond) can provide inhibitors with extraordinary affinity (low nanomolar) for the model lectin, galectin-3, which is more than five orders of magnitude higher than the parent galactose; moreover, is selective over other galectins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Engineering the Ligand Specificity of the Human Galectin-1 by Incorporation of Tryptophan Analogues

Felix Tobola, Martin Lepsik, Syeda Rehana Zia, Hakon Leffler, Ulf J. Nilsson, Ola Blixt, Anne Imberty, Birgit Wiltschi

Summary: This study introduced non-canonical tryptophan analogues into the ligand binding site of Galectin-1 and found two variants with reduced affinity for certain sugars. Through fluorescence polarization competition assay and molecular modeling, the researchers provided structural clues for the changes in affinity.

CHEMBIOCHEM (2022)

Article Biochemistry & Molecular Biology

Installation of O-glycan sulfation capacities in human HEK293 cells for display of sulfated mucins

Lingbo Sun, Andriana Konstantinidi, Zilu Ye, Rebecca Nason, Yuecheng Zhang, Christian Bull, Barbro Kahl-Knutson, Lars Hansen, Hakon Leffler, Sergey Y. Vakhrushev, Zhang Yang, Henrik Clausen, Yoshiki Narimatsu

Summary: Researchers engineered sulfotransferase genes in HEK293 cells to achieve sulfation modification of O-glycans. They used this engineered cell library to study the binding specificity between galectin-4 and sulfated O-glycans.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Galectin-9 Signaling Drives Breast Cancer Invasion through Extracellular Matrix

Dharma Pally, Mallar Banerjee, Shahid Hussain, Rekha Kumar, Alexandra Petersson, Ebba Rosendal, Ludvig Gunnarsson, Kristoffer Peterson, Hakon Leffler, Ulf J. Nilsson, Ramray Bhat

Summary: Aberrations in glycan and lectin expression and function contribute to the development of cancer. This study focused on Galectin-9, a member of the beta-galactoside-binding lectin family, and investigated its role in breast cancer cell invasiveness. The results showed a correlation between Galectin-9 expression and the ability of invasive cancer cells to adhere and invade extracellular matrix microenvironments. Further experiments revealed that Galectin-9 induced Focal Adhesion Kinase activity and S100A4 expression, which are associated with cancer cell invasion. The findings provide crucial insights into the mechanisms by which elevated Galectin-9 expression enhances breast cancer cell invasiveness during the early stages of invasion.

ACS CHEMICAL BIOLOGY (2022)

Article Chemistry, Medicinal

Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia

Khuchtumur Bum-Erdene, Patrick M. Collins, Matthew W. Hugo, Somayeh S. Tarighat, Fei Fei, Chandan Kishor, Hakon Leffler, Ulf J. Nilsson, John Groffen, I. Darren Grice, Nora Heisterkamp, Helen Blanchard

Summary: In this study, novel Galectin-3 antagonists with enhanced affinity and selectivity were designed and synthesized. Experimental results demonstrated the specific inhibition of Galectin-3-induced BCP-ALL cell agglutination and decreased viability of ALL cells. Therefore, these compounds show promise as important leads for cancer therapeutics.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Immunology

Galectin-8 Downmodulates TLR4 Activation and Impairs Bacterial Clearance in a Mouse Model of Pseudomonas aeruginosa Keratitis

Abdulraouf Ramadan, Zhiyi Cao, Mujtaba Hassan, Fredrik Zetterberg, Ulf J. Nilsson, Mihaela Gadjeva, Vijay Rathinam, Noorjahan Panjwani

Summary: In this study, researchers found that galectin-8 (Gal-8), a carbohydrate-binding protein, plays an important role in regulating the innate immune response to Pseudomonas aeruginosa keratitis. Gal-8-/- mice were resistant to the infection, while mice deficient in other galectins were susceptible. The addition of exogenous Gal-8 suppressed the activation of the TLR4 pathway and improved bacterial killing capacity by neutrophils. Moreover, injecting a Gal-8 inhibitor reduced the severity of infection in a mouse model. These findings have implications for developing new therapeutic strategies for conditions resulting from an overactive immune response.

JOURNAL OF IMMUNOLOGY (2023)

Article Cell Biology

Increased Galectin-9 Levels Correlate with Disease Activity in Patients with DMARD-Naive Rheumatoid Arthritis and Modulate the Secretion of MCP-1 and IL-6 from Synovial Fibroblasts

Morten A. A. Nielsen, Ditte Koster, Akul Y. Y. Mehta, Kristian Stengaard-Pedersen, Pierre Busson, Peter Junker, Kim Horslev-Petersen, Merete Lund Hetland, Mikkel ostergaard, Malene Hvid, Hakon Leffler, Tue W. W. Kragstrup, Richard D. D. Cummings, Bent Deleuran

Summary: This study evaluated the clinical and pathogenic aspects of Gal-9 in rheumatoid arthritis (RA) and found that it plays a role in modulating synovial FLS activities and maintaining subclinical disease activity.
Article Oncology

Safety and pharmacokinetics of GB1211, an oral galectin-3 inhibitor: a single- and multiple-dose first-in-human study in healthy participants

Vassilios Aslanis, Robert J. Slack, Alison C. MacKinnon, Catherine McClinton, Susan Tantawi, Lise Gravelle, Ulf J. Nilsson, Hakon Leffler, Ashley Brooks, Sanjeev K. Khindri, Richard P. Marshall, Anders Pedersen, Hans Schambye, Fredrik Zetterberg

Summary: GB1211 is an orally bioavailable galectin-3 inhibitor that plays a potential role in treating chronic inflammation, heart disease, and cancer. The study demonstrated that GB1211 is well tolerated, rapidly absorbed, and has favorable pharmacokinetics in healthy participants, supporting its further clinical development.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2023)

Article Cell Biology

N-BAR and F-BAR proteins-endophilin-A3 and PSTPIP1-control clathrin-independent endocytosis of L1CAM

Camille Lemaigre, Apolline Ceuppens, Cesar Augusto Valades-Cruz, Benjamin Ledoux, Bastien Vanbeneden, Mujtaba Hassan, Fredrik R. Zetterberg, Ulf J. Nilsson, Ludger Johannes, Christian Wunder, Henri-Francois Renard, Pierre Morsomme

Summary: This study investigates the endocytosis of L1CAM and its role in nervous system development, cancer development, and metastasis prognosis. It reveals that there are two isoforms of L1CAM that undergo endocytosis mediated by N-BAR and F-BAR domain proteins, as well as galectins. These findings are important for understanding the pathophysiological role of L1CAM.

TRAFFIC (2023)

Article Chemistry, Medicinal

Ligand Sulfur Oxidation State Progressively Alters Galectin-3-Ligand Complex Conformations To Induce Affinity-Influencing Hydrogen Bonds

Mukul Mahanti, Kumar Bhaskar Pal, Rohit Kumar, Markus Schulze, Hakon Leffler, Derek T. Logan, Ulf J. Nilsson

Summary: The sulfur oxidation state of galactoside ligands affects the thermodynamics and structure of their interactions with galectin-3.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Medicinal

Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease

Fredrik R. Zetterberg, Alison MacKinnon, Thomas Brimert, Lise Gravelle, Richard E. Johnsson, Barbro Kahl-Knutson, Hakon Leffler, Ulf J. Nilsson, Anders Pedersen, Kristoffer Peterson, James A. Roper, Hans Schambye, Robert J. Slack, Susan Tantawi

Summary: This study presents a series of selective galectin-3 inhibitors with high affinity and oral bioavailability. These compounds show antifibrotic activity in fibrosis-related diseases and one of them has been selected as a clinical candidate for further research.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Medicinal

Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease

Fredrik R. Zetterberg, Alison MacKinnon, Thomas Brimert, Lise Gravelle, Richard E. Johnsson, Barbro Kahl-Knutson, Hakon Leffler, Ulf J. Nilsson, Anders Pedersen, Kristoffer Peterson, James A. Roper, Hans Schambye, Robert J. Slack, Susan Tantawi

Summary: Galectin-3 is a crucial carbohydrate-binding protein involved in the regulation of various diseases. The discovery of GB0139, a high-affinity drug for idiopathic pulmonary fibrosis, has opened up new possibilities for treatment. By optimizing physical and chemical parameters, a series of highly selective galectin-3 inhibitors with both high affinity and oral bioavailability have been developed. These compounds have demonstrated anti-fibrotic activity in liver and lung fibrosis mouse models and show promising pharmacokinetic and safety profiles. GB1211 has been selected as a clinical candidate for liver cirrhosis and cancer, and phase IIa clinical trials are currently underway.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Chemistry, Multidisciplinary

Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1,-3 and-8 inhibitors

Sjors van Klaveren, Jaka Dernovsek, Ziga Jakopin, Marko Anderluh, Hakon Leffler, Ulf J. Nilsson, Tihomir Tomasic

Summary: Galectins are proteins that can bind to galactosides and play a crucial role in drug discovery. The authors have designed a series of aromatic 3-triazolyl-1-thiogalactosides and evaluated their binding affinities with different Galectins.

RSC ADVANCES (2022)

Article Chemistry, Multidisciplinary

Direct sialic acid 4-OAc substitution by nitrogen, sulfur and carbon nucleophiles with retention of stereochemistry

Tiago Bozzola, Ulf J. Nilsson, Ulf Ellervik

Summary: A direct one-step nucleophilic substitution method for the 4-OAc of acetyl protected Neu5Ac is presented. The method allows for a wider range of nitrogen nucleophiles, thiols, and cyanide to be used compared to previously published methods, which were limited to cyclic secondary amines. This investigation significantly expands the scope of 4-aminations and enables the introduction of a variety of nucleophiles.

RSC ADVANCES (2022)

暂无数据